Abcodia is a clinical stage company engaged in the commercial development of novel, scientifically validated tests for the early detection of cancer. The Company’s first product is the ROCA® Test for the early detection of ovarian cancer, and is also expanding its pipeline of early detection technologies for lung, colorectal and pancreatic cancer.
We maintain exclusive commercial access to a biobank of prospectively collected samples donated from over 200,000 individuals over a 10-year period. In addition, we hold strategic collaborations with leading global organizations including Cancer Research UK, University College London and other academic and industry partners.
